DOCSLIB.ORG

Infectious Diseases of Tanzania

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

INFECTIOUS DISEASES OF TANZANIA Stephen Berger, MD Infectious Diseases of Tanzania - 2014 edition Infectious Diseases of Tanzania - 2014 edition Stephen Berger, MD Copyright © 2014 by GIDEON Informatics, Inc. All rights reserved. Published by GIDEON Informatics, Inc, Los Angeles, California, USA. www.gideononline.com Cover design by GIDEON Informatics, Inc No part of this book may be reproduced or transmitted in any form or by any means without written permission from the publisher. Contact GIDEON Informatics at [email protected]. ISBN: 978-1-4988-0208-6 Visit http://www.gideononline.com/ebooks/ for the up to date list of GIDEON ebooks. DISCLAIMER Publisher assumes no liability to patients with respect to the actions of physicians, health care facilities and other users, and is not responsible for any injury, death or damage resulting from the use, misuse or interpretation of information obtained through this book. Therapeutic options listed are limited to published studies and reviews. Therapy should not be undertaken without a thorough assessment of the indications, contraindications and side effects of any prospective drug or intervention. Furthermore, the data for the book are largely derived from incidence and prevalence statistics whose accuracy will vary widely for individual diseases and countries. Changes in endemicity, incidence, and drugs of choice may occur. The list of drugs, infectious diseases and even country names will vary with time. Scope of Content Disease designations may reflect a specific pathogen (ie, Adenovirus infection), generic pathology (Pneumonia - bacterial) or etiologic grouping (Coltiviruses - Old world). Such classification reflects the clinical approach to disease allocation in the Infectious Diseases Module of the GIDEON web application. Similarly, a number of diseases which are generally diagnosed and treated outside of the field of Infectious Diseases are not included, despite the fact that a clear infectious etiology exists. Examples include Peptic ulcer, Tropical spastic paraparesis, Hairy-cell leukemia, Creutzfeldt-Jakob disease, Human papilloma virus infections, etc. In contrast, a number of other entities of unknown etiology which do present to Infectious Diseases specialists have been included: Kawasaki's disease, Chronic fatigue syndrome, Kikuchi and Kimura diseases. Several minor infections having minimal relevance to the field of Geographic Medicine are not covered: Paronychia, Otitis externa, Molluscum contagiosum, etc. © 2014 GIDEON Informatics, Inc. www.gideononline.com All Rights Reserved. Page 1 of 423 Infectious Diseases of Tanzania - 2014 edition Introduction: The GIDEON e-book series Infectious Diseases of Tanzania is one in a series of GIDEON ebooks which summarize the status of individual infectious diseases, in every country of the world. Data are based on the GIDEON web application (www.gideononline.com) which relies on standard text books, peer-review journals, Health Ministry reports and ProMED, supplemented by an ongoing search of the medical literature. Chapters are arranged alphabetically, by disease name. Each section is divided into four sub-sections: 1. Descriptive epidemiology 2. Summary of clinical features 3. Status of the disease in Tanzania 4. References The initial items in the first section, Descriptive epidemiology, are defined as follows: Agent Classification (e.g., virus, parasite) and taxonomic designation. Reservoir Any animal, arthropod, plant, soil or substance in which an infectious agent normally lives and multiplies, on which it depends primarily for survival, and where it reproduces itself in such a manner that it can be transmitted to a susceptible host. Vector An arthropod or other living carrier which transports an infectious agent from an infected organism or reservoir to a susceptible individual or immediate surroundings. Vehicle The mode of transmission for an infectious agent. This generally implies a passive and inanimate (i.e., non-vector) mode. A chapter outlining the routine vaccination schedule of Tanzania follows the diseases chapters. There are 352 generic infectious diseases in the world today. 226 of these are endemic, or potentially endemic, to Tanzania. A number of other diseases are not relevant to Tanzania and have not been included in this book. In addition to endemic diseases, we have included all published data regarding imported diseases and infection among expatriates from Tanzania. The availability and quality of literature regarding specific infectious diseases vary from country to country. As such, you may find that many of the sections in this book are limited to a general discussion of the disease itself - with no data regarding Tanzania. This is a book about the geography and epidemiology of Infection. Comprehensive and up-to-date information regarding the causes, diagnosis and treatment of each disease is available in the GIDEON web application. Many of the diseases are generic. For example, such designations as Pneumonia bacterial and Urinary tract infection include a number of individual diseases. These appear under the subheading, Synonyms, listed under each disease. We welcome feedback, and will be pleased to add any relevant, sourced material. Email us at [email protected] For more information about GIDEON see the section About GIDEON and visit www.gideononline.com Last updated: April 3, 2014 © 2014 GIDEON Informatics, Inc. www.gideononline.com All Rights Reserved. Page 2 of 423 Infectious Diseases of Tanzania - 2014 edition Table of Contents Introduction: The GIDEON e-book series ......................... 2 Cytomegalovirus infection+ ...........................................95 Actinomycosis .............................................................. 6 Dengue+ ....................................................................97 Adenovirus infection+.................................................... 8 Dermatophytosis ....................................................... 100 Aeromonas & marine Vibrio infx. .................................. 10 Dientamoeba fragilis infection .....................................101 African tick bite fever+ ................................................ 12 Diphtheria+ .............................................................. 102 AIDS+....................................................................... 14 Diphyllobothriasis ...................................................... 105 Amoeba - free living ................................................... 21 Dipylidiasis+ ............................................................. 106 Amoebic abscess+ ...................................................... 23 Dirofilariasis ............................................................. 107 Amoebic colitis+ ......................................................... 24 Dracunculiasis* ......................................................... 108 Animal bite-associated infection ................................... 26 Echinococcosis - unilocular+........................................ 110 Anisakiasis ................................................................ 27 Echinostomiasis ........................................................ 113 Anthrax+ ................................................................... 29 Endocarditis - infectious ............................................. 114 Ascariasis+ ................................................................ 34 Enterobiasis+ ............................................................ 115 Aspergillosis .............................................................. 36 Enterovirus infection .................................................. 117 Babesiosis*................................................................ 37 Epidural abscess ....................................................... 119 Bacillary angiomatosis................................................. 39 Erysipelas or cellulitis................................................. 120 Bacillus cereus food poisoning ...................................... 40 Erysipeloid ............................................................... 121 Bacterial vaginosis+ .................................................... 41 Erythrasma .............................................................. 122 + Balantidiasis+............................................................. 43 Escherichia coli diarrhea ........................................... 123 Bartonellosis - cat borne.............................................. 44 Fascioliasis+ ............................................................. 125 Bartonellosis - other systemic+..................................... 46 Filariasis - Bancroftian+ .............................................. 127 Bertiella and Inermicapsifer+........................................ 48 Fungal infection - invasive+ ........................................ 130 Blastocystis hominis infection....................................... 49 Gastroenteritis - viral+ ............................................... 133 Blastomycosis+ .......................................................... 50 Gianotti-Crosti syndrome............................................ 135 Botulism.................................................................... 52 Giardiasis+ ............................................................... 136 Brain abscess............................................................. 54 Gnathostomiasis ....................................................... 138 Brucellosis+ ..............................................................
Recommended publications
  • Balantidium Coli

    Balantidium Coli

    GLOBAL WATER PATHOGEN PROJECT PART THREE. SPECIFIC EXCRETED PATHOGENS: ENVIRONMENTAL AND EPIDEMIOLOGY ASPECTS BALANTIDIUM COLI Francisco Ponce-Gordo Complutense University Madrid, Spain Kateřina Jirků-Pomajbíková Institute of Parasitology Biology Centre, ASCR, v.v.i. Budweis, Czech Republic Copyright: This publication is available in Open Access under the Attribution-ShareAlike 3.0 IGO (CC-BY-SA 3.0 IGO) license (http://creativecommons.org/licenses/by-sa/3.0/igo). By using the content of this publication, the users accept to be bound by the terms of use of the UNESCO Open Access Repository (http://www.unesco.org/openaccess/terms-use-ccbysa-en). Disclaimer: The designations employed and the presentation of material throughout this publication do not imply the expression of any opinion whatsoever on the part of UNESCO concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. The ideas and opinions expressed in this publication are those of the authors; they are not necessarily those of UNESCO and do not commit the Organization. Citation: Ponce-Gordo, F., Jirků-Pomajbíková, K. 2017. Balantidium coli. In: J.B. Rose and B. Jiménez-Cisneros, (eds) Global Water Pathogens Project. http://www.waterpathogens.org (R. Fayer and W. Jakubowski, (eds) Part 3 Protists) http://www.waterpathogens.org/book/balantidium-coli Michigan State University, E. Lansing, MI, UNESCO. Acknowledgements: K.R.L. Young, Project Design editor; Website Design (http://www.agroknow.com) Published: January 15, 2015, 11:50 am, Updated: October 18, 2017, 5:43 pm Balantidium coli Summary 1.1.1 Global distribution Balantidium coli is reported worldwide although it is To date, Balantidium coli is the only ciliate protozoan more common in temperate and tropical regions (Areán and reported to infect the gastrointestinal track of humans.
  • New Zealand's Genetic Diversity

    New Zealand's Genetic Diversity

    1.13 NEW ZEALAND’S GENETIC DIVERSITY NEW ZEALAND’S GENETIC DIVERSITY Dennis P. Gordon National Institute of Water and Atmospheric Research, Private Bag 14901, Kilbirnie, Wellington 6022, New Zealand ABSTRACT: The known genetic diversity represented by the New Zealand biota is reviewed and summarised, largely based on a recently published New Zealand inventory of biodiversity. All kingdoms and eukaryote phyla are covered, updated to refl ect the latest phylogenetic view of Eukaryota. The total known biota comprises a nominal 57 406 species (c. 48 640 described). Subtraction of the 4889 naturalised-alien species gives a biota of 52 517 native species. A minimum (the status of a number of the unnamed species is uncertain) of 27 380 (52%) of these species are endemic (cf. 26% for Fungi, 38% for all marine species, 46% for marine Animalia, 68% for all Animalia, 78% for vascular plants and 91% for terrestrial Animalia). In passing, examples are given both of the roles of the major taxa in providing ecosystem services and of the use of genetic resources in the New Zealand economy. Key words: Animalia, Chromista, freshwater, Fungi, genetic diversity, marine, New Zealand, Prokaryota, Protozoa, terrestrial. INTRODUCTION Article 10b of the CBD calls for signatories to ‘Adopt The original brief for this chapter was to review New Zealand’s measures relating to the use of biological resources [i.e. genetic genetic resources. The OECD defi nition of genetic resources resources] to avoid or minimize adverse impacts on biological is ‘genetic material of plants, animals or micro-organisms of diversity [e.g. genetic diversity]’ (my parentheses).
  • WO 2014/134709 Al 12 September 2014 (12.09.2014) P O P C T

    WO 2014/134709 Al 12 September 2014 (12.09.2014) P O P C T

    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2014/134709 Al 12 September 2014 (12.09.2014) P O P C T (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every A61K 31/05 (2006.01) A61P 31/02 (2006.01) kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, (21) International Application Number: BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, PCT/CA20 14/000 174 DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, (22) International Filing Date: HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, 4 March 2014 (04.03.2014) KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, (25) Filing Language: English OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, (26) Publication Language: English SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, (30) Priority Data: ZW. 13/790,91 1 8 March 2013 (08.03.2013) US (84) Designated States (unless otherwise indicated, for every (71) Applicant: LABORATOIRE M2 [CA/CA]; 4005-A, rue kind of regional protection available): ARIPO (BW, GH, de la Garlock, Sherbrooke, Quebec J1L 1W9 (CA). GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, (72) Inventors: LEMIRE, Gaetan; 6505, rue de la fougere, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, Sherbrooke, Quebec JIN 3W3 (CA).
  • Blastocystis Hominis Transmission by Non-Potable Water: a Case Report In

    Blastocystis Hominis Transmission by Non-Potable Water: a Case Report In

    NEW MICROBIOLOGICA, 41, 2, 173-177, 2018, ISN 1121-7138 CASE REPORT Blastocystis hominis transmission by non-potable water: a case report in Italy Maria Cristina Angelici, Chiara Nardis, Riccardo Scarpelli, Paola Ade Department of Environment and Health, Istituto Superiore di Sanità, Rome, Italy SUMMARY In the reported case, a 41-year-old Italian man came to the clinician’s observation reporting cramps, bloat- ing and watery diarrhoea a few days after drinking water indicated as unpotable from a fountain in a farm area. The medical suspicion was directed at both gluten intolerance and enteric infection, eventually of waterborne origin. Gluten intolerance was investigated by intestinal biopsy and excluded, while stool analyses ruled out infective bacteriological or viral agents and parasites. Subsequently, a persistent eo- sinophilia was revealed and a parasitological analysis was again suggested, planning for a more sensitive molecular method. Therefore, a multiplex-PCR of enteric protozoa species DNA was performed on an intestinal biopsy and faecal samples revealing only Blastocystis hominis protozoa, subsequently typed as subtype 1 by RFLP-PCR method. B. hominis is an anaerobic protozoa found in the human and animal intestinal tract, recently associated with a pathogenic role characterized by chronic development. Since blastocystosis has been demonstrated as a waterborne infection, a sample of water matrix was analysed, revealing the B. hominis subtype 1 DNA inside. A probable water transmission of Blastocystis infection has been demonstrated in this case report. Only a probiotic treatment based on Saccharomyces boulardii was administered to the patient and this apparently resolved the infection. In summary, the case described here is a chronic blastocystosis of possible waterborne origin, controlled by assuming a yeast treatment.
  • Wda 2016 Conference Proceedi

    Wda 2016 Conference Proceedi

    The 65th International Conference of the Wildlife Disease Association July 31 August 5, 2016 Cortland, New York Sustainable Wildlife: Health Matters! Hosted by at Greek Peak Mountain Resort Cortland, New York, USA 4 Wildlife Disease Association Table of Contents Welcome from the Conference Committee 6 Conference Committee Members 7 WDA Officers 8 Plenary Speakers 9 The 2016 Carlton Herman Fund Speaker 11 Sponsors 12 Events & Meetings 15 Pre-conference Workshops 17 Program 21 Poster Sessions 34 Abstracts 40 Exhibitors 249 Index 256 65th Annual International Conference 5 Welcome from the Conference Committee Welcome to beautiful central New York, the 65th International Conference of the Wildlife Disease Association, and the 2016 Annual Meeting of the American Association of Wildlife Veterinarians. We have planned an exciting scientific program and have lots of networking and learning opportunities in store this week. There will be a break mid-week to allow time to socialize with new and old friends and take in some of the adventures the area has to offer. global challenges and opportunities in managing wildlife health issues with our excellent slate of plenary speakers. In addition, we have three special sessions: How Risk Communication Research in Wildlife Disease Management Contributes to Wildlife Trust Administration, Chelonian Diseases and Conservation, and Vaccines for Conservation. This meeting would not have been possible without the contributions of numerous people and institutions. We are grateful to Cornell University for in-kind and financial support for this event. The Atkinson Center for a Sustainable Future, College of Veterinary Medicine, Department of Population Medicine and Diagnostic Sciences, Animal Health Diagnostic Center, and Lab of Ornithology have all been integral parts of making this meeting a success.
  • Specimen Type, Collection Methods, and Diagnostic Assays Available For

    Specimen Type, Collection Methods, and Diagnostic Assays Available For

    Specimen type, collection methods, and diagnostic assays available for the detection of poxviruses from human specimens by the Poxvirus and Rabies Branch, Centers for Disease Control and Prevention1. Specimen Orthopoxvirus Parapoxvirus Yatapoxvirus Molluscipoxvirus Specimen type collection method PCR6 Culture EM8 IHC9,10 Serology11 PCR12 EM8 IHC9,10 PCR13 EM8 PCR EM8 Lesion material Fresh or frozen Swab 5 Lesion material [dry or in media ] [vesicle / pustule Formalin fixed skin, scab / crust, etc.] Paraffin block Fixed slide(s) Container Lesion fluid Swab [vesicle / pustule [dry or in media5] fluid, etc.] Touch prep slide Blood EDTA2 EDTA tube 7 Spun or aliquoted Serum before shipment Spun or aliquoted Plasma before shipment CSF3,4 Sterile 1. The detection of poxviruses by electron microscopy (EM) and immunohistochemical staining (IHC) is performed by the Infectious Disease Pathology Branch of the CDC. 2. EDTA — Ethylenediaminetetraacetic acid. 3. CSF — Cerebrospinal fluid. 4. In order to accurately interpret test results generated from CSF specimens, paired serum must also be submitted. 5. If media is used to store and transport specimens a minimal amount should be used to ensure as little dilution of DNA as possible. 6. Orthopoxvirus generic real-time polymerase chain reaction (PCR) assays will amplify DNA from numerous species of virus within the Orthopoxvirus genus. Species-specific real-time PCR assays are available for selective detection of DNA from variola virus, vaccinia virus, monkeypox virus, and cowpox virus. 7. Blood is not ideal for the detection of orthopoxviruses by PCR as the period of viremia has often passed before sampling occurs. 8. EM can reveal the presence of a poxvirus in clinical specimens or from virus culture, but this technique cannot differentiate between virus species within the same genus.
  • Enteric Protozoa in the Developed World: a Public Health Perspective

    Enteric Protozoa in the Developed World: a Public Health Perspective

    Enteric Protozoa in the Developed World: a Public Health Perspective Stephanie M. Fletcher,a Damien Stark,b,c John Harkness,b,c and John Ellisa,b The ithree Institute, University of Technology Sydney, Sydney, NSW, Australiaa; School of Medical and Molecular Biosciences, University of Technology Sydney, Sydney, NSW, Australiab; and St. Vincent’s Hospital, Sydney, Division of Microbiology, SydPath, Darlinghurst, NSW, Australiac INTRODUCTION ............................................................................................................................................420 Distribution in Developed Countries .....................................................................................................................421 EPIDEMIOLOGY, DIAGNOSIS, AND TREATMENT ..........................................................................................................421 Cryptosporidium Species..................................................................................................................................421 Dientamoeba fragilis ......................................................................................................................................427 Entamoeba Species.......................................................................................................................................427 Giardia intestinalis.........................................................................................................................................429 Cyclospora cayetanensis...................................................................................................................................430
  • | Oa Tai Ei Rama Telut Literatur

    | Oa Tai Ei Rama Telut Literatur

    |OA TAI EI US009750245B2RAMA TELUT LITERATUR (12 ) United States Patent ( 10 ) Patent No. : US 9 ,750 ,245 B2 Lemire et al. ( 45 ) Date of Patent : Sep . 5 , 2017 ( 54 ) TOPICAL USE OF AN ANTIMICROBIAL 2003 /0225003 A1 * 12 / 2003 Ninkov . .. .. 514 / 23 FORMULATION 2009 /0258098 A 10 /2009 Rolling et al. 2009 /0269394 Al 10 /2009 Baker, Jr . et al . 2010 / 0034907 A1 * 2 / 2010 Daigle et al. 424 / 736 (71 ) Applicant : Laboratoire M2, Sherbrooke (CA ) 2010 /0137451 A1 * 6 / 2010 DeMarco et al. .. .. .. 514 / 705 2010 /0272818 Al 10 /2010 Franklin et al . (72 ) Inventors : Gaetan Lemire , Sherbrooke (CA ) ; 2011 / 0206790 AL 8 / 2011 Weiss Ulysse Desranleau Dandurand , 2011 /0223114 AL 9 / 2011 Chakrabortty et al . Sherbrooke (CA ) ; Sylvain Quessy , 2013 /0034618 A1 * 2 / 2013 Swenholt . .. .. 424 /665 Ste - Anne -de - Sorel (CA ) ; Ann Letellier , Massueville (CA ) FOREIGN PATENT DOCUMENTS ( 73 ) Assignee : LABORATOIRE M2, Sherbrooke, AU 2009235913 10 /2009 CA 2567333 12 / 2005 Quebec (CA ) EP 1178736 * 2 / 2004 A23K 1 / 16 WO WO0069277 11 /2000 ( * ) Notice : Subject to any disclaimer, the term of this WO WO 2009132343 10 / 2009 patent is extended or adjusted under 35 WO WO 2010010320 1 / 2010 U . S . C . 154 ( b ) by 37 days . (21 ) Appl. No. : 13 /790 ,911 OTHER PUBLICATIONS Definition of “ Subject ,” Oxford Dictionary - American English , (22 ) Filed : Mar. 8 , 2013 Accessed Dec . 6 , 2013 , pp . 1 - 2 . * Inouye et al , “ Combined Effect of Heat , Essential Oils and Salt on (65 ) Prior Publication Data the Fungicidal Activity against Trichophyton mentagrophytes in US 2014 /0256826 A1 Sep . 11, 2014 Foot Bath ,” Jpn .
  • Catalogue of Protozoan Parasites Recorded in Australia Peter J. O

    Catalogue of Protozoan Parasites Recorded in Australia Peter J. O

    1 CATALOGUE OF PROTOZOAN PARASITES RECORDED IN AUSTRALIA PETER J. O’DONOGHUE & ROBERT D. ADLARD O’Donoghue, P.J. & Adlard, R.D. 2000 02 29: Catalogue of protozoan parasites recorded in Australia. Memoirs of the Queensland Museum 45(1):1-164. Brisbane. ISSN 0079-8835. Published reports of protozoan species from Australian animals have been compiled into a host- parasite checklist, a parasite-host checklist and a cross-referenced bibliography. Protozoa listed include parasites, commensals and symbionts but free-living species have been excluded. Over 590 protozoan species are listed including amoebae, flagellates, ciliates and ‘sporozoa’ (the latter comprising apicomplexans, microsporans, myxozoans, haplosporidians and paramyxeans). Organisms are recorded in association with some 520 hosts including mammals, marsupials, birds, reptiles, amphibians, fish and invertebrates. Information has been abstracted from over 1,270 scientific publications predating 1999 and all records include taxonomic authorities, synonyms, common names, sites of infection within hosts and geographic locations. Protozoa, parasite checklist, host checklist, bibliography, Australia. Peter J. O’Donoghue, Department of Microbiology and Parasitology, The University of Queensland, St Lucia 4072, Australia; Robert D. Adlard, Protozoa Section, Queensland Museum, PO Box 3300, South Brisbane 4101, Australia; 31 January 2000. CONTENTS the literature for reports relevant to contemporary studies. Such problems could be avoided if all previous HOST-PARASITE CHECKLIST 5 records were consolidated into a single database. Most Mammals 5 researchers currently avail themselves of various Reptiles 21 electronic database and abstracting services but none Amphibians 26 include literature published earlier than 1985 and not all Birds 34 journal titles are covered in their databases. Fish 44 Invertebrates 54 Several catalogues of parasites in Australian PARASITE-HOST CHECKLIST 63 hosts have previously been published.
  • The Approved List of Biological Agents Advisory Committee on Dangerous Pathogens Health and Safety Executive

    The Approved List of Biological Agents Advisory Committee on Dangerous Pathogens Health and Safety Executive

    The Approved List of biological agents Advisory Committee on Dangerous Pathogens Health and Safety Executive © Crown copyright 2021 First published 2000 Second edition 2004 Third edition 2013 Fourth edition 2021 You may reuse this information (excluding logos) free of charge in any format or medium, under the terms of the Open Government Licence. To view the licence visit www.nationalarchives.gov.uk/doc/ open-government-licence/, write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email [email protected]. Some images and illustrations may not be owned by the Crown so cannot be reproduced without permission of the copyright owner. Enquiries should be sent to [email protected]. The Control of Substances Hazardous to Health Regulations 2002 refer to an ‘approved classification of a biological agent’, which means the classification of that agent approved by the Health and Safety Executive (HSE). This list is approved by HSE for that purpose. This edition of the Approved List has effect from 12 July 2021. On that date the previous edition of the list approved by the Health and Safety Executive on the 1 July 2013 will cease to have effect. This list will be reviewed periodically, the next review is due in February 2022. The Advisory Committee on Dangerous Pathogens (ACDP) prepares the Approved List included in this publication. ACDP advises HSE, and Ministers for the Department of Health and Social Care and the Department for the Environment, Food & Rural Affairs and their counterparts under devolution in Scotland, Wales & Northern Ireland, as required, on all aspects of hazards and risks to workers and others from exposure to pathogens.
  • Risk Groups: Viruses (C) 1988, American Biological Safety Association

    Risk Groups: Viruses (C) 1988, American Biological Safety Association

    Rev.: 1.0 Risk Groups: Viruses (c) 1988, American Biological Safety Association BL RG RG RG RG RG LCDC-96 Belgium-97 ID Name Viral group Comments BMBL-93 CDC NIH rDNA-97 EU-96 Australia-95 HP AP (Canada) Annex VIII Flaviviridae/ Flavivirus (Grp 2 Absettarov, TBE 4 4 4 implied 3 3 4 + B Arbovirus) Acute haemorrhagic taxonomy 2, Enterovirus 3 conjunctivitis virus Picornaviridae 2 + different 70 (AHC) Adenovirus 4 Adenoviridae 2 2 (incl animal) 2 2 + (human,all types) 5 Aino X-Arboviruses 6 Akabane X-Arboviruses 7 Alastrim Poxviridae Restricted 4 4, Foot-and- 8 Aphthovirus Picornaviridae 2 mouth disease + viruses 9 Araguari X-Arboviruses (feces of children 10 Astroviridae Astroviridae 2 2 + + and lambs) Avian leukosis virus 11 Viral vector/Animal retrovirus 1 3 (wild strain) + (ALV) 3, (Rous 12 Avian sarcoma virus Viral vector/Animal retrovirus 1 sarcoma virus, + RSV wild strain) 13 Baculovirus Viral vector/Animal virus 1 + Togaviridae/ Alphavirus (Grp 14 Barmah Forest 2 A Arbovirus) 15 Batama X-Arboviruses 16 Batken X-Arboviruses Togaviridae/ Alphavirus (Grp 17 Bebaru virus 2 2 2 2 + A Arbovirus) 18 Bhanja X-Arboviruses 19 Bimbo X-Arboviruses Blood-borne hepatitis 20 viruses not yet Unclassified viruses 2 implied 2 implied 3 (**)D 3 + identified 21 Bluetongue X-Arboviruses 22 Bobaya X-Arboviruses 23 Bobia X-Arboviruses Bovine 24 immunodeficiency Viral vector/Animal retrovirus 3 (wild strain) + virus (BIV) 3, Bovine Bovine leukemia 25 Viral vector/Animal retrovirus 1 lymphosarcoma + virus (BLV) virus wild strain Bovine papilloma Papovavirus/
  • Blastocystosis in Patients with Gastrointestinal Symptoms: a Case

    Blastocystosis in Patients with Gastrointestinal Symptoms: a Case

    Cekin et al. BMC Gastroenterology 2012, 12:122 http://www.biomedcentral.com/1471-230X/12/1/122 RESEARCH ARTICLE Open Access Blastocystosis in patients with gastrointestinal symptoms: a case–control study Ayhan Hilmi Cekin1*, Yesim Cekin2, Yesim Adakan3, Ezel Tasdemir3, Fatma Gulsun Koclar4 and Basak Oguz Yolcular5 Abstract Background: Blastocystosis is a frequent bowel disease. We planned to to evaluate the prevalence of Blastocystis spp. in patients who applied to the same internal medicine-gastroenterology clinic with or without gastrointestinal complaints to reveal the association of this parasite with diagnosed IBS and IBD. Methods: A total of 2334 patients with gastrointestinal symptoms composed the study group, which included 335 patients with diagnosed inflammatory bowel disease and 877 with irritable bowel syndrome. Patients without any gastrointestinal symptoms or disease (n = 192) composed the control group. Parasite presence was investigated by applying native-Lugol and formol ethyl acetate concentration to stool specimens, and trichrome staining method in suspicious cases. Results: Blastocystis spp. was detected in 134 patients (5.74%) in the study group and 6 (3.12%) in the control group (p = 0.128). In the study group, Blastocystis spp. was detected at frequencies of 8.7% in ulcerative colitis (24/276), 6.78% in Crohn’s disease (4/59), 5.82% in irritable bowel syndrome (51/877), and 4.9% in the remaining patients with gastrointestinal symptoms (55/1122). Blastocystis spp. was detected at a statistically significant ratio in the inflammatory bowel disease (odds ratio [OR] = 2.824; 95% confidence interval [CI]: 1.149-6.944; p = 0.019) and ulcerative colitis (OR = 2.952; 95% CI: 1.183-7.367; p = 0.016) patients within this group compared to controls.